Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

2.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Ovarian Cycle01:27

Ovarian Cycle

5.5K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.5K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

5.2K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to letter to editor (P.S Coder and J.D Vidal) regarding "Rodent estrous cycle pattern: Harmonizing the cycle evaluation and interpretation- S. Holalagoudar et al., 2025".

Regulatory toxicology and pharmacology : RTP·2025
Same author

An Approach to Setting Vertebrate Animal-use Benchmarks for Agrochemical and GM Crop Testing to Facilitate Future Animal Reduction Efforts.

Alternatives to laboratory animals : ATLA·2025
Same author

Bioinformatic workflows for deriving transcriptomic points of departure: current status, data gaps, and research priorities.

Toxicological sciences : an official journal of the Society of Toxicology·2024
Same author

Progress in toxicogenomics to protect human health.

Nature reviews. Genetics·2024
Same author

Discovery Phase Agrochemical Predictive Safety Assessment Using High Content <i>In Vitro</i> Data to Estimate an <i>In Vivo</i> Toxicity Point of Departure.

Journal of agricultural and food chemistry·2024
Same author

Utilizing functional genomics in Saccharomyces cerevisiae to characterize food preservative compounds: A pilot study.

Journal of food science·2024
Same journal

The NTP Chronic Inhalation Study Does Not Support an Inherent Lung Cancer Hazard of Talc: Implications of Lung Particle Overload and Maximum Tolerated Dose.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Consideration of Carcinogenicity and Mode of Action Information by an Independent Expert Panel to Support Derivation of No-Significant-Risk-Level Values for Vinyl Acetate Monomer.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Which carcinogenicity study should I use? Automated identification of reliable studies.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Adoption of artificial intelligence in drug review across the lifecycle: Transformation of regulatory decision-making.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Cardiovascular outcomes following intrauterine and lactational exposure to cyantraniliprole in male Wistar rats.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Pesticide residue and mycotoxin occurrence in apples and their impact on human health in Morocco.

Regulatory toxicology and pharmacology : RTP·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification
09:01

Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification

Published on: September 15, 2012

112.6K

Rodent estrous cycle pattern: Harmonizing the cycle evaluation and interpretation.

Shivakumar Holalagoudar1, Susan Kisielewski1, Austin Martini1

  • 1Corteva Agriscience, Haskell R&D Center, 1090 Elkton Road, Newark, DE, 19711, USA.

Regulatory Toxicology and Pharmacology : RTP
|December 24, 2024
PubMed
Summary
This summary is machine-generated.

Estrous cycle timing in rodent reproductive toxicity studies can vary, especially with extended estrus stages. Harmonizing methods is crucial for accurate endocrine disruptor assessments.

Keywords:
Cycle lengthEstrous cycleOECD guidanceRodents

More Related Videos

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

13.3K
Rodent Estrous Cycle Monitoring Utilizing Vaginal Lavage: No Such Thing As a Normal Cycle
09:05

Rodent Estrous Cycle Monitoring Utilizing Vaginal Lavage: No Such Thing As a Normal Cycle

Published on: August 30, 2021

7.3K

Related Experiment Videos

Last Updated: May 6, 2026

Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification
09:01

Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification

Published on: September 15, 2012

112.6K
Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

13.3K
Rodent Estrous Cycle Monitoring Utilizing Vaginal Lavage: No Such Thing As a Normal Cycle
09:05

Rodent Estrous Cycle Monitoring Utilizing Vaginal Lavage: No Such Thing As a Normal Cycle

Published on: August 30, 2021

7.3K

Area of Science:

  • Reproductive toxicology
  • Endocrinology
  • Animal models

Background:

  • The estrous cycle is a key indicator in reproductive toxicity studies, particularly for assessing endocrine disruptors.
  • Current methods for estrous cycle timing show discrepancies among testing laboratories.

Purpose of the Study:

  • To review methods for estrous cycle timing and evaluation in rodent reproductive toxicity studies.
  • To identify and address inconsistencies in estrous cycle counting, particularly concerning extended estrus stages.

Main Methods:

  • Review of existing literature and testing laboratory protocols for estrous cycle evaluation.
  • Analysis of discrepancies in cycle counting, focusing on extended estrus (E) and proestrus (P) phases.

Main Results:

  • No significant differences were found in counting standard 4-day estrous cycles.
  • Discrepancies arise when extended episodes of estrus occur, leading to potential misinterpretation of results.
  • Current OECD guidance may be unclear for 5-day cycles involving extended estrus stages.

Conclusions:

  • Standardization of estrous cycle counting is needed, especially for 4/5-day cycles with extended estrus.
  • Recommendations include updating OECD guidance and defining abnormal cycle patterns (e.g., two E after P, three consecutive E).
  • Collaboration is encouraged to harmonize estrous cycle counting approaches for reliable toxicity assessments.